Enhabit’s (EHAB) Market Perform Rating Reiterated at Leerink Partners

Leerink Partners reissued their market perform rating on shares of Enhabit (NYSE:EHABFree Report) in a research note released on Tuesday,Benzinga reports. Leerink Partners currently has a $8.00 price target on the stock, down from their previous price target of $8.50.

Enhabit Trading Down 0.6 %

EHAB stock opened at $7.41 on Tuesday. The company has a quick ratio of 1.46, a current ratio of 1.46 and a debt-to-equity ratio of 0.85. Enhabit has a 52-week low of $6.85 and a 52-week high of $11.74. The company’s 50-day simple moving average is $7.52 and its 200-day simple moving average is $8.42. The firm has a market cap of $372.69 million, a P/E ratio of -3.19 and a beta of 1.84.

Enhabit (NYSE:EHABGet Free Report) last issued its quarterly earnings data on Wednesday, November 6th. The company reported $0.03 EPS for the quarter, missing the consensus estimate of $0.04 by ($0.01). The business had revenue of $253.60 million during the quarter, compared to analyst estimates of $261.69 million. Enhabit had a negative net margin of 11.24% and a positive return on equity of 1.67%. During the same period in the previous year, the business posted $0.03 earnings per share. As a group, equities analysts forecast that Enhabit will post 0.25 EPS for the current fiscal year.

Institutional Trading of Enhabit

A number of institutional investors and hedge funds have recently modified their holdings of EHAB. SummerHaven Investment Management LLC boosted its holdings in Enhabit by 2.8% in the 2nd quarter. SummerHaven Investment Management LLC now owns 61,508 shares of the company’s stock worth $549,000 after buying an additional 1,660 shares during the last quarter. FMR LLC increased its position in shares of Enhabit by 138.4% during the third quarter. FMR LLC now owns 3,388 shares of the company’s stock worth $27,000 after purchasing an additional 1,967 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its holdings in Enhabit by 5.8% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 37,950 shares of the company’s stock valued at $443,000 after purchasing an additional 2,078 shares in the last quarter. Quarry LP lifted its holdings in Enhabit by 242.2% in the 2nd quarter. Quarry LP now owns 3,703 shares of the company’s stock valued at $33,000 after purchasing an additional 2,621 shares in the last quarter. Finally, Gladius Capital Management LP boosted its stake in Enhabit by 78.2% during the 3rd quarter. Gladius Capital Management LP now owns 6,259 shares of the company’s stock worth $49,000 after purchasing an additional 2,747 shares during the last quarter.

Enhabit Company Profile

(Get Free Report)

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.

Recommended Stories

Analyst Recommendations for Enhabit (NYSE:EHAB)

Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.